Salisbury, MD, Sept. 13, 2017 -- Dr. Nishant Rao, medical director of Diet Doc – a nationally-based medical weight loss program seeks to clear up misconceptions about the role that insulin levels play when it comes to weight loss. The GOLO diet plan is a fad diet, which peaked in its popularity in 2016, is a program designed to cause weight loss by managing insulin levels (operating under the false belief that calorie intake is not a factor in weight loss or gain). The GOLO diet has three phases or tiers: Intervention, Meal Plan and Roadmap. Dr. Rao takes issue with this tier-based system, noting that “The tiers use common over-the-counter products as supplements; all of which have negligible impacts on blood sugar and insulin. Though some ingredients can work as a laxative, which is a common strategy among weight loss OTC pills.”
|
||||||
Consequently, there are more issues with this style of dieting. “Many people who have blood sugar levels within normal range and don’t have insulin resistance will find little benefit in this niche diet,” says Dr. Rao. Also keep in mind that the GOLO diet also refers insulin states which are not referenced in scientific literature, such as insulin maintenance or insulin performance (which isn’t a thing). Furthermore, all ingredients in GOLO diet supplements are readily available over-the-counter at a very low cost and most of the of the diet’s benefits can be readily attained through simple healthy eating. Simply put, Dr. Rao says, “There isn’t anything breakthrough about this diet.”
Diet Doc acknowledges that some patients have insulin resistance behind their struggles with weight management. “For these people Diet Doc has two formulated compounded prescription medications which will decrease blood glucose and improve insulin resistance at a much more potent level of action,” says Dr. Rao. Any patient struggling with insulin resistance can utilize these prescriptions after a thorough consultation and approval by one of Diet Doc’s certified physicians. At Diet Doc, insulin levels can be managed in conjunction with individualized diet planning and doctor supervision for fast, effective weight loss and health improvements overall.
Give us a call to schedule a consultation with a licensed medical professional and receive instant access to Diet Doc’s powerful prescription weight loss aids. Diet Doc physicians all received specialized training in nutritional science and fast weight loss. Diet Doc reviews each patient’s health history to create a personalized diet plan geared for fast weight loss, or that addresses life-long issues causing weight loss to slow down or stop. Nutritionists work personally with each patient and use their own algorithm to craft meal and snack plans that are compatible with each patient’s age, gender, activity level, food preferences, nutritional needs and medical conditions. They combine these state of the art diet plans with pure, prescription diet products that enable their patients to resist the temptation to reach for sugary snacks, eliminate fatigue and curb the appetite. Over 97% of Diet Doc patients report incredible weight loss results with the majority losing 20 or more pounds per month.
At Diet Doc, all patients gain unlimited access to the best minds in the business. Their staff of doctors, nurses, nutritionists and coaches are available six days per week to answer questions, offer suggestions, address concerns and lend their professional guidance and support. Because of this, more and more people are turning to Diet Doc for their weight management needs. Diet plans are tailored to be specific to the needs of those of any age, gender, shape or size and for those who are struggling to lose that final 10-20 pounds to those who must lose 100 pounds or more. Call today to request a private, confidential, no-cost online consultation.
About the Company:
Diet Doc Weight Loss is the nation's leader in medical, weight loss offering a full line of prescription medication, doctor, nurse and nutritional coaching support. For over a decade, Diet Doc has produced a sophisticated, doctor designed weight loss program that addresses each individual specific health need to promote fast, safe and long-term weight loss.
Diet Doc Contact Information:
Providing care across the USA
Headquarters:
San Diego, CA
(800) 311-5610
Twitter: https://twitter.com/DietDocMedical
Facebook: https://www.facebook.com/DietDocMedicalWeightLoss/
Linkedin: https://www.linkedin.com/company/diet-doc-weight-loss?trk=biz-brand-tree-co-logo
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a67bc748-ee44-4bd4-b6b7-43d23ca23a84
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c6495312-e0a0-4948-86cf-185313e5a842
Julie Wright Diet Doc 800-311-5610 [email protected]


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



